Current opinions on how to identify and treat NTRK fusion positive cancer

MEET THE EXPERTS ALL PROGRAMMES DEVELOPED COLLABORATIONS CONTACT

Current opinions on how to identify and treat NTRK fusion positive cancer

Prof. David Hong, Prof. Ezra Cohen, Prof. Frederique Penault-Llorca

We recently delivered a virtual Experts Knowledge Share meeting discussing how to identify, test and treat NTRK fusion positive cancer.

Prof. David Hong

Medical Oncologist

MD Anderson Cancer Center, Houston

United States (US)

Prof. Ezra Cohen

Medical Oncologist

Moores Cancer Center, San Diego

United States (US)

Prof. Frederique Penault-Llorca

Pathologist

University of Clermont-Ferrand

France

time BluePrint Resource | open 5 min |accreditation: EACCME

download resources

PDF FILE

PPTX FILE

I agree that this educational programme:

Was valuable to me:

1/3

Has improved my knowledge of this topic:

2/3

Is likely to change my clinical practice:

3/3

This programme is supported by an Independent Educational Grant from Bayer

Other programmes of interest

TRK fusion-positive cancer highlights from ASCO 2022

Jun 2022

Podcast: management of skin toxicity with multikinase inhibitors

Update from ASCO 2022 - Rectal cancer & mCRC

Jun 2022

Response to immunotherapy in HCC: Real-world experience and treat...

Jun 2022

Update from ASCO 2022 - Sarcoma

Update From ASCO 2022 - Selected LBAs

May 2022

Timing of ARSI and taxanes for mCSPC

Jul 2022

Using immunohistochemistry to detect TRK fusion-positive cancer

May 2022

Rare bone disease symposium at ECE 2022

Jun 2022

Accreditation: EACCME

Diagnosis and Management of Bone Sarcoma

Prostate Cancer Highlights from ASCO GU 2022

Mar 2022

Young-onset colorectal cancer

Mar 2022

Other programmes developed by Prof. Ezra Cohen

Prof. Ezra Cohen

Medical Oncologist

Moores Cancer Center, San Diego

United States (US)

NTRK CONNECT Update from ASCO 2020

May 2020

Key Publication Snapshot 3 – Characterisation of adverse events...

Oct 2020

Other programmes developed by Prof. Frederique Penault-Llorca

Prof. Frederique Penault-Llorca

Pathologist

University of Clermont-Ferrand

France

Using immunohistochemistry to detect TRK fusion-positive cancer

May 2022

Podcast: TRK fusion-positive GI cancers

Oct 2021

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.